Cytochromes P450 as promising catalysts for biotechnological application: chances and limitations

R Bernhardt, VB Urlacher - Applied microbiology and biotechnology, 2014 - Springer
Cytochromes P450 (CYPs) belong to the superfamily of heme b containing
monooxygenases with currently more than 21,000 members. These enzymes accept a vast …

Toward the development of smart and low cost point-of-care biosensors based on screen printed electrodes

MU Ahmed, MM Hossain, M Safavieh… - Critical reviews in …, 2016 - Taylor & Francis
Screen printing technology provides a cheap and easy means to fabricate disposable
electrochemical devices in bulk quantities which are used for rapid, low-cost, on-site, real …

Cytochrome P450 (CYP) enzymes and the development of CYP biosensors

E Schneider, DS Clark - Biosensors and Bioelectronics, 2013 - Elsevier
Cytochrome P450s (CYPs) are a large family of heme-containing monooxygenase enzymes
involved in the first-pass metabolism of drugs and foreign chemicals in the body. CYP …

Optimization of the bacterial cytochrome P450 BM3 system for the production of human drug metabolites

G Di Nardo, G Gilardi - International Journal of Molecular Sciences, 2012 - mdpi.com
Drug metabolism in human liver is a process involving many different enzymes. Among
them, a number of cytochromes P450 isoforms catalyze the oxidation of most of the drugs …

Recent developments in microfluidic devices for in vitro cell culture for cell-biology research

D Gao, H Liu, Y Jiang, JM Lin - TrAC Trends in Analytical Chemistry, 2012 - Elsevier
Microfluidics has developed as a powerful tool for cell-biology research due to its intrinsic
advantages. Recently, considerable progress was made in microfluidic technology for cell …

Cytochrome P450 enzymes: a review on drug metabolizing enzyme inhibition studies in drug discovery and development

SN Rao Gajula, MS Pillai, G Samanthula, R Sonti - Bioanalysis, 2021 - Taylor & Francis
Assessment of drug candidate's potential to inhibit cytochrome P450 (CYP) enzymes
remains crucial in pharmaceutical drug discovery and development. Both direct and time …

Chimeric P 450 enzymes: Activity of artificial redox fusions driven by different reductases for biotechnological applications

SJ Sadeghi, G Gilardi - Biotechnology and Applied …, 2013 - Wiley Online Library
This review covers the current state of knowledge regarding artificial fusion constructs of
cytochrome P 450 enzymes in which the activity of the catalytic heme is driven by reductases …

Electrochemical Biosensor for Evaluation of Environmental Pollutants Toxicity

MS Islam, K Sazawa, K Sugawara, H Kuramitz - Environments, 2023 - mdpi.com
Electrochemical biosensors that combine high selectivity of biochemical affinity with precise
electrochemical detection are one of the most necessary and powerful tools for assessing …

Bioelectrochemical platform with human monooxygenases: FMO1 and CYP3A4 tandem reactions with phorate

H Cheropkina, G Catucci, F Cesano, A Marucco… - …, 2023 - Elsevier
It is highly advantageous to devise an in vitro platform that can predict the complexity of an in
vivo system. The first step of this process is the identification of a xenobiotic whose …

Electrochemistry in the mimicry of oxidative drug metabolism by cytochrome P450s

E Nouri-Nigjeh, R Bischoff, A P. Bruins… - Current drug …, 2011 - benthamdirect.com
Prediction of oxidative drug metabolism at the early stages of drug discovery and
development requires fast and accurate analytical techniques to mimic the in vivo oxidation …